MEDS Trxade Group Inc

USD 10.24 0.69 7.225131
Icon

Trxade Group Inc (MEDS) Stock Analysis and Price Targets

COMMON STOCK | Pharmaceutical Retailers | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 10.24

+0.69 (+7.23)%

USD 0.03B

0.11M

N/A

N/A

Icon

MEDS

Trxade Group Inc (USD)
COMMON STOCK | NSD
USD 10.24
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.03B

N/A

USD 10.24

Trxade Group Inc (MEDS) Stock Forecast

N/A

Based on the Trxade Group Inc stock forecast from 0 analysts, the average analyst target price for Trxade Group Inc is not available over the next 12 months. Trxade Group Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Trxade Group Inc is Slightly Bearish, which is based on 3 positive signals and 7 negative signals. At the last closing, Trxade Group Inc’s stock price was USD 10.24. Trxade Group Inc’s stock price has changed by -52.70% over the past week, +20.47% over the past month and +89.63% over the last year.

No recent analyst target price found for Trxade Group Inc
No recent average analyst rating found for Trxade Group Inc

Company Overview Trxade Group Inc

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace,...Read More

2420 Brunello Trace, Lutz, FL, United States, 33558

33

December

USD

USA

Adjusted Closing Price for Trxade Group Inc (MEDS)

Loading...

Unadjusted Closing Price for Trxade Group Inc (MEDS)

Loading...

Share Trading Volume for Trxade Group Inc Shares

Loading...

Compare Performance of Trxade Group Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for MEDS

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Trxade Group Inc (Sector: Pharmaceutical Retailers )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
WBA
Walgreens Boots Alliance Inc +0.67 (+3.19%) USD17.77B 31.23 20.86

ETFs Containing MEDS

Symbol Name MEDS's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Trxade Group Inc (MEDS) Stock

Stock Target Advisor's fundamental analysis for Trxade Group Inc's stock is Slightly Bearish.

MEDS stock's dividend yield is 27.44%. Our analysis grades MEDS stock's dividend yield at A+. This means that MEDS stock's dividend yield is above 100% of the stocks in the Pharmaceutical Retailers sector in the NSD exchange. Based on this MEDS may be a good dividend stock for its sector.

Unfortunately we do not have enough data on MEDS's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on MEDS's stock to indicate if its overvalued.

The last closing price of MEDS's stock was USD 10.24.

The most recent market capitalization for MEDS is USD 0.03B.

Unfortunately we do not have enough analyst data on MEDS's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Trxade Group Inc's stock.

As per our most recent records Trxade Group Inc has 33 Employees.

Trxade Group Inc's registered address is 2420 Brunello Trace, Lutz, FL, United States, 33558. You can get more information about it from Trxade Group Inc's website at https://www.trxadehealth.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...